Combination Improves Anticancer Activity of 2 Agents in Acute Myeloid Leukemia

Combination Improves Anticancer Activity of 2 Agents in Acute Myeloid Leukemia

In this study, researchers sought to enhance the anticancer effects of birinapant, which is a SMAC-mimetic. SMAC is a pro-apoptotic molecule. The researchers, from the Walter and Eliza Hall Institute in Parkville, Victoria, Australia, screened kinase

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.